Skip to main content
TipRanks
Go Ultimate75% OFF

Santen Pharmaceutical Co (SZD) Q3 2023 Earnings Report

0 Followers

DE:SZD Q3 2023 EPS Results

Actual EPS
EUR 0.11
Consensus EPS
EUR 0.09
Beat/Miss
Beat by +EUR 0.02
One Year Ago EPS
EUR 0.08

DE:SZD Q3 2023 Revenue Results

Actual Revenue
EUR 434.02M
Expected Revenue
EUR 415.27M
Beat/Miss
Beat by +EUR 18.75M
YoY Revenue Growth
+8.69%

Earnings Announcement Details

Quarter
Q3 2023
Date
02/08/2024
Time
TBA
Conference Call
Thursday, February 8, 2024
DE:SZD Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q3 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:SZD Earnings History

DE:SZD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 09, 20272026 (Q3)0.21-0.14――
Nov 05, 20262026 (Q2)0.180.140.145.03% (+0.01)
Aug 06, 20262026 (Q1)0.120.130.129.21% (+0.03)
May 12, 20262025 (Q4)0.170.270.1585.80% (+0.12)
Feb 05, 20262025 (Q3)0.170.140.14-3.67% (-0.01)
Nov 06, 20252025 (Q2)0.120.140.134.94% (+0.01)
Aug 07, 20252025 (Q1)0.130.100.17-41.47% (-0.07)
May 13, 20252024 (Q4)0.100.150.0957.30% (+0.05)
Feb 06, 20252024 (Q3)0.150.140.1125.40% (+0.03)
Nov 07, 20242024 (Q2)0.120.130.14-3.48% (-0.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed